| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 09/27/2006 | EP1335906B1 Pyrimidine derivatives and their use as neuropeptide y receptor ligands |
| 09/27/2006 | EP1303537B1 Ho-1 suppressor as a diagnostic and prognostic test for dementing diseases |
| 09/27/2006 | EP0983765B1 Preventives or remedies for diseases in association with vascular functional anomaly relating to insulin resistance |
| 09/27/2006 | CN1839131A Azolidinecarbonitriles and their use as DPP-IV inhibitors |
| 09/27/2006 | CN1838949A Pharmaceutical composition comprising a combination of metformin and a statin |
| 09/27/2006 | CN1838946A Pharmaceutical formulations of amyloid inhibiting compounds |
| 09/27/2006 | CN1838890A Corrective clothes with liner |
| 09/27/2006 | CN1837207A Pirazino(aza)indole derivatives |
| 09/27/2006 | CN1837202A Flavonols with blood-fat-lowering effect |
| 09/27/2006 | CN1837197A Salvianolic acid M and rosmarinic acid as aldose reductase inhibitor in sage |
| 09/27/2006 | CN1836717A Quality controlling method for pulse restoring injection |
| 09/27/2006 | CN1836708A Aliphatic acid synthase inhibitor and method for making same and uses |
| 09/27/2006 | CN1836704A Nutritious calcium tablet |
| 09/27/2006 | CN1836698A Medicine composition for treating hyperlipemia and coronary disease and preparation method thereof |
| 09/27/2006 | CN1836695A Compound grease-reducing drop pills preparation method |
| 09/27/2006 | CN1836694A Medicine composition for treating cardiovascular diseases and preparation method thereof |
| 09/27/2006 | CN1836689A Tablet containing F.tataricum and spirulina spp. , and its preparation method |
| 09/27/2006 | CN1836688A Freeze-drying powder injection containing red-rooted salvia safflower |
| 09/27/2006 | CN1836679A Tablet spirulina spp for invigorating yang , and its preparation method |
| 09/27/2006 | CN1836678A Tablet spirulina spp for invigorating yang , and its preparation method |
| 09/27/2006 | CN1836675A Tablet containing lucid ganoderma and spirulina spp. ,and its preparation method |
| 09/27/2006 | CN1836666A Water-soluble vitamin for injection and its preparation process and quality control method |
| 09/27/2006 | CN1836657A Polymethoxylated flavones and its preparation method |
| 09/27/2006 | CN1836655A Electrolyte replenisher for treating hypopotassaemia hypomagnesemia and its uses |
| 09/27/2006 | CN1836653A Rosiglitazone slow-release tablet and its preparation method |
| 09/27/2006 | CN1276974C Gsk3 polypeptides |
| 09/27/2006 | CN1276970C New strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it |
| 09/27/2006 | CN1276920C Thiazolidinedione derivatives and pharmaceutical composition comprising the same |
| 09/27/2006 | CN1276748C Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation |
| 09/26/2006 | US7112607 Antihypoxic agents, antiischamic agents, antiarrhythmia agents |
| 09/26/2006 | US7112606 Heterocyclic arylsulfonamidobenzylic compounds |
| 09/26/2006 | US7112603 Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 09/26/2006 | US7112597 5-(Substituted thiazolylethoxy)indaneacetic acid derivatives, used in the treatment of diseases such as diabetes, obesity, hyperlipidemia, and atherosclerotic diseases |
| 09/26/2006 | US7112593 N-aryl-substituted cyclic amine derivative and medicine containing the same as active ingredient |
| 09/26/2006 | US7112586 Substituted diamine derivatives useful as motilin antagonists |
| 09/26/2006 | US7112562 Insulin conjugates and methods of use thereof |
| 09/26/2006 | CA2254953C Therapies for chronic renal failure |
| 09/24/2006 | CA2539281A1 Methods for the treatment of insulin resistance and disease states characterized by insulin resistance |
| 09/21/2006 | WO2006099480A2 Stress proteins and peptides and methods of use thereof |
| 09/21/2006 | WO2006098604A1 Pharmaceutical composition for preventing and treating diabetes or glucose control abnormality comprising ginsenosides |
| 09/21/2006 | WO2006098519A1 Pyrazolopyrimidine derivative or pharmaceutically acceptable salt thereof |
| 09/21/2006 | WO2006098394A1 Method for inhibiting lipid absorption and lipid absorption inhibitor |
| 09/21/2006 | WO2006098342A1 Piperazinyl compounds |
| 09/21/2006 | WO2006098314A1 Novel sugar uptake activator and method for screening the same |
| 09/21/2006 | WO2006097793A2 Compositions capable of facilitating penetration across a biological barrier |
| 09/21/2006 | WO2006097625A1 Novel imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same |
| 09/21/2006 | WO2006097605A1 Pharmaceutical compositions containing a combination of a cannabinoid receptor antagonist compound and an antipsychotic agent |
| 09/21/2006 | WO2006097536A2 Dimeric peptide agonists of the glp-1 receptor |
| 09/21/2006 | WO2006097460A1 Hydroxamates as histone deacetylase inhibitors and pharmaceutical formulations containing them |
| 09/21/2006 | WO2006097337A2 11β-HYDROXYSTEROID DEHYDROGENASES |
| 09/21/2006 | WO2006097273A1 Compounds having immunomodulator activity |
| 09/21/2006 | WO2006097220A1 Pyrimidine carboxylic acid derivatives and use thereof |
| 09/21/2006 | WO2006097169A1 Trifluoromethylbenzamide derivatives and therapeutic uses thereof |
| 09/21/2006 | WO2006097090A1 Retinol for reducing risk factors of arteriosclerosis and/or increasing insulin sensitivity |
| 09/21/2006 | WO2006080412A3 Cyanopyrrolidine derivative-containing composition for solid pharmaceutical preparations, solid pharmaceutical preparation containing the composition, and process for producing the solid pharmaceutical preparation |
| 09/21/2006 | WO2006079077A3 Use of diltiazem or analogs thereof as modulators of ghrelin receptor |
| 09/21/2006 | WO2006076231A8 Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level |
| 09/21/2006 | WO2006060456A3 Indole derivatives for use as ppar ppar active compounds |
| 09/21/2006 | WO2006010557A8 D-glucopyranosyl phenyl-substituted cyclene, medicaments containing these compounds, their use, and method for the production thereof |
| 09/21/2006 | WO2006007412A9 Peptide yy formulations having increased stability and resistance to microbial agents |
| 09/21/2006 | WO2005112897A3 Immediate release pharmaceutical tablets with height greater than width |
| 09/21/2006 | WO2004089282A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 09/21/2006 | US20060212109 Delivery of therapeutic capable agents |
| 09/21/2006 | US20060211764 Cell activator, process for producing cell activator and apparatus therefor |
| 09/21/2006 | US20060211761 Hmg-coa-reductase inhibitors |
| 09/21/2006 | US20060211760 Indolamide derivatives which possess glycogen phosphorylase inhibitory activity |
| 09/21/2006 | US20060211755 3-oxo-1, 3-dihydro-indazole-2-carboxylic acid amide derivatives as phospholipase inhibitors |
| 09/21/2006 | US20060211701 Use of von tetrahydrobiopterine derivatives in the treatment and nutrition of patients with amino acid metabolic disorders |
| 09/21/2006 | US20060211696 IMIDAZO[1,2-b]PYRIDAZINE COMPOUND |
| 09/21/2006 | US20060211694 antiinflammatory agent for treating asthma and chronic pulmonary inflammatory disease |
| 09/21/2006 | US20060211682 Hexahydrodiazepinones as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 09/21/2006 | US20060211664 Method for treating erectile dysfunction and increasing libido in men |
| 09/21/2006 | US20060211661 24 hydroxyvitamin d, analogs and uses thereof |
| 09/21/2006 | US20060211654 Pharmaceutical Compositions of Cholesteryl Ester Transfer Protein Inhibitor |
| 09/21/2006 | US20060211631 Transfusion preparation for peripheral intravenous administration and method of stabilizing vitamin b1 |
| 09/21/2006 | US20060211613 Administering parathyroid hormone and bone resorption inhibitor; bone disorders |
| 09/21/2006 | US20060211609 Novel agent for improving neurotransmission failure |
| 09/21/2006 | US20060211607 Somatostatin-dopamine chimeric analogs |
| 09/21/2006 | US20060211150 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance |
| 09/21/2006 | US20060211149 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance |
| 09/21/2006 | US20060211143 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance |
| 09/21/2006 | US20060211142 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance |
| 09/21/2006 | US20060210963 Induction of a Beta Cell Differentiation in Human Cells |
| 09/21/2006 | US20060210565 Antagonists of HMG1 for treating inflammatory conditions |
| 09/21/2006 | DE102005012875A1 Verwendung von Amino substituierten 8-N-Benzimidazolen Use of amino-substituted 8-N-benzimidazoles |
| 09/21/2006 | DE102005012874A1 Amid substituierte 8-N-Benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Amide substituted 8-N-benzimidazoles, process for their preparation and their use as medicaments |
| 09/21/2006 | DE102005012831A1 Herstellung eines Arzneimittels zur Senkung des Risikofaktors der Artherosklerose und/oder Erhöhung der Insulinsensitivität Manufacture of a medicament for reducing the risk factor of atherosclerosis and / or increasing insulin sensitivity |
| 09/21/2006 | DE102004039532B4 Cyclohexyl-methyloxy substituierte Essigsäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel Cyclohexyl-methyloxy-substituted acetic acid derivatives, process for their preparation and their use as medicaments |
| 09/21/2006 | DE102004039509B4 Aryl-cycloalkyl substituierte Alkansäurederivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Aryl-cycloalkyl substituted alkane acid derivatives, processes for their preparation and their use as medicaments |
| 09/21/2006 | CA2601717A1 Pyrazolopyrimidine derivative or pharmaceutically acceptable salt thereof |
| 09/21/2006 | CA2600904A1 Trifluoromethylbenzamide derivatives and therapeutic uses thereof |
| 09/21/2006 | CA2600681A1 Pyrimidine carboxylic acid derivatives and use thereof |
| 09/21/2006 | CA2600528A1 Hydroxamates as histone deacetylase inhibitors and pharmaceutical formulations containing them |
| 09/21/2006 | CA2600028A1 Pharmaceutical compositions containing a combination of a cannabinoid receptor antagonist compound and an antipsychotic agent |
| 09/21/2006 | CA2599643A1 Novel imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same |
| 09/21/2006 | CA2581402A1 Novel activating agent of glucose uptake and a screening method therefor |
| 09/21/2006 | CA2563533A1 Compositions capable of facilitating penetration across a biological barrier |
| 09/21/2006 | CA2500750A1 Liquid compound added to the preparation of cigarette, cigar and pipe tobacco and chewing tobacco. designed to reduce the risk of disease caused by tobacco smoke. |
| 09/20/2006 | EP1702920A1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/20/2006 | EP1702919A1 Novel 2-heteroaryl-substituted benzimidazole derivative |